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ABSTRACT
Asthma is a heterogeneous disease with varying phenotypes and numerous risk factors. This condition results
from complex interactions between genetic and environmental factors, and active smoking is one of these risk
factors. The effects of aging should also be taken into account in these interactions. From an epidemiological
standpoint, smokers andor elderly patients with asthma are not small part in the total population with asthma.
Furthermore, both smoking and aging are important risk factors for severe asthma. This review discusses the
potential effects of smoking and aging on healthy subjects and patients with asthma, particularly from the per-
spective of inflammatory changes. First we show evidence that smokers and the elderly have increased neutro-
phil counts in their airways, which may have impacts on their clinical characteristics of elderly smokers with
asthma. Secondly, on the basis of our recent findings on the interactions between smoking and aging in pa-
tients with asthma, we propose that IgEeosinophilic inflammation should not be underestimated in elderly
smokers with asthma, particularly those who are atopic. This review may expand our understanding of the ef-
fects of smoking and aging on asthma with a new perspective of an old issue.
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INTRODUCTION
It is well known that current smokers with asthma
have poorer disease control1-3 and show an excessive
declines in forced expiratory volume in 1 second
(FEV1)4 compared with never-smokers with asthma.
Smoking may also impair therapeutic responses to in-
haled5 and oral corticosteroids6 in patients with
asthma. Currently, mechanisms underlying the char-
acteristics of smokers with asthma are mostly ex-
plained by the induction of neutrophilic airway in-
flammation7-9 and goblet cell hyperplasia,10 whereas
studies on the relationship between smoking and
eosinophilic inflammation in patients with asthma
have yielded inconsistent findings.7,8,10,11 Nonethe-
less, considering that smoking is related to higher se-
rum IgE levels in the general population12-14 and that
relatively young patients with asthma are enrolled in
studies on smokers with asthma,7,8,11 the involvement
of IgEeosinophilic inflammation in smokers with
asthma should be re-evaluated in all age groups.
In the first part of this review, we summarize the
evidence for the effects of smoking on asthma. We
also address the impact of ex-smoking on the patho-
physiology in this condition. Next, we review evi-
dence for the effects of aging on asthma and offer in-
sights into the interactions between smoking and age
on IgEeosinophilic inflammation in patients with
asthma.
ASTHMA AND SMOKING
EPIDEMIOLOGY
The prevalence of smokers among adult patients with
asthma is similar to that among the general popula-
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tion. In Western countries, 17%-35% patients with
asthma are current smokers, while 22%-43% patients
are ex-smokers.15 In a survey of Japanese adult pa-
tients with asthma (n = 400) in 2005, Adachi et al. re-
ported that the percentage of current smokers with
asthma was 20.5%, which was similar to the general
population (21.7% in 2009 according to the Ministry of
Health, Labour and Welfare, Japan), while that of ex-
smokers with asthma was 24.5%.16 In another recent
study in Japan, Ikeue et al. reported that the percent-
age of current smokers among patients with asthma
who visited emergency department due to asthma at-
tack was 34.8%.17 In our university hospital, 15.0% pa-
tients with asthma were current smokers while ap-
proximately 21.2% were ex-smokers as shown later.
Passive smoking is a risk factor for the develop-
ment of asthma. Studies on maternal smoking during
pregnancy, parental smoking during childhood, and
passive smoking in the workplace consistently dem-
onstrate that passive smoking is related to the onset
of asthma and respiratory symptoms.18-20 Recent
studies, including a population-based incident case-
control study, show that active smoking also causes
asthma in adulthood,21-23 although it did not increase
the risk of asthma onset in earlier studies.24,25 Fur-
thermore, in a recent longitudinal study, allergic pa-
tients who smoked were more prone to newly de-
velop asthma of greater severity.26 Ex-smoking may
also be a risk factor for the development of asthma, as
Piipari et al. showed that ex-smoking increased the
risk of asthma by 1.34 in males and 2.38 in females.22
However, some analyses do not support this risk of
asthma onset among ex-smokers.26
CLINICAL CHARACTERISTICS
Current smokers with asthma consistently have more
severe symptoms and poorer asthma control than
never-smokers with asthma,1-3,15,27 while ex-smokers
have poorer asthma control than never-smokers.1
Current smoking or passive smoking increases ad-
mission rates and decreases quality of life in patients
with asthma.28 The mortality rate is higher among
current smokers with asthma than among never-
smokers with asthma.29 Current smokers are less
likely to manage their asthma compared with never-
smokers, possibly because they lack knowledge
about asthma, use inhaled corticosteroids less fre-
quently, and attend asthma education programs less
frequently compared with never-smokers.30-32
DECLINES IN LUNG FUNCTION
The combination of current smoking and asthma has
a synergistic4 or an additive effect on the decline in
FEV1.33 In a 15-year follow-up of adults with asthma in
the Copenhagen City Heart Study, among male pa-
tients with asthma aged 40-59 years, current smokers
and never- or ex-smokers showed an average annual
decline in FEV1 of 58 ml and 33 ml, respectively.4
THERAPEUTIC RESPONSES IN SMOKING
ASTHMATICS
Current smokers with asthma, and to a lesser extent,
ex-smokers with asthma are resistant to oral corti-
costeroids, although their airways show reversibility
to an inhaled short-acting β2 agonist.6 Similarly, cur-
rent smokers with asthma are insensitive to inhaled
corticosteroid treatment,5,34 particularly when low
doses of inhaled corticosteroids are used.35 Several
mechanisms for corticosteroid resistance in smokers
with asthma have been suggested: (a) increased pro-
duction of tumor necrosis factor-α with overexpres-
sion of glucocorticoid receptor β, (b) increased pro-
duction of interleukin (IL)-4, (c) overexpression of
nuclear factor-κB, (d) decreased histone deacetylase
activity, and (e) increased numbers of neutrophils
and CD8+ T cells.6
In contrast to treatment with corticosteroids, cur-
rent smokers with asthma may benefit from treat-
ment with a leukotriene receptor antagonist. After 8
weeks of treatment with a leukotriene-receptor an-
tagonist, morning peak flow increased to a greater ex-
tent in current smokers with asthma than in never-
smokers with asthma.33 Smoking-induced increases
in urinary excretion of leukotriene E4 in patients with
asthma may have been involved in this effect.36
IMMUNE SYSTEM AND AIRWAY INFLAMMA-
TORY CELL PHENOTYPES
Cigarette smoking alters immune inflammatory re-
sponses in many ways. Smoking compromises host
defense by suppressing innate immune responses in
conjunction with impairing mucociliary clearance and
epithelial junction.37 Meanwhile, cigarette smoke acti-
vates resident cells toward a pro-inflammatory status
and recruits inflammatory cells into the airways.38
The effects of smoking on innate immunity in asth-
matic airways have not been completely determined.
However, it is interesting to note that among several
Toll-like receptors (TLRs) that play key roles in in-
nate immune responses, the expression of TLR2,
which recognizes gram-positive bacteria, fungi, and
rhinovirus capsids,39 may be altered in smokers with
asthma compared to never-smokers with asthma.
In never-smokers with asthma, the mRNA expres-
sion of TLR2 in sputum, but not of TLR3 or TLR4,
was increased compared to healthy subjects.40 TLR2
expression was higher during acute asthma attacks,
particularly viral-induced asthma attacks, than in the
stable condition.40 Of note, for patients with fatal
asthma who smoked, the expression of TLR2, but not
of TLR3 or TLR4, in the small airways was lower than
that in never-smokers with fatal asthma.41 This was
consistent with findings of decreased TLR2 expres-
sion in smokers.42 Although the subsequent changes
in adaptive immune responses have not been shown,
suppression of TLR2 may be involved in the altered
the immune system in smokers with asthma.43
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During the development of adaptive immune-
inflammatory responses, dendritic cells play an im-
portant role in the differentiation of Th-1- and Th-2
type inflammation. Dendritic cells that develop under
nicotine exposure have a defect in their Th-1-
promoting capacity and promote Th-2 responses,
which are augmented in a Th-2-biased environment.44
Indeed, smoking skews the immune inflammatory re-
sponses toward Th-2-type inflammation in healthy
subjects.45,46 Serum immunoglobulin E (IgE) lev-
els12-14 and blood eosinophil counts14,47,48 of current
smokers are higher than those of never-smokers in
the general population.
Cigarette smoking significantly alters the types of
airway inflammatory cells. Recent studies on Th-17-
type inflammation show that IL-17 levels are in-
creased in the airways of smokers. Because IL-17 re-
cruits and activates neutrophils,49 systemic and local
increases in neutrophil counts in healthy current
smokers50-52 may be partly induced by Th-17-type in-
flammation53 concomitant with the release of the neu-
trophil chemoattractant IL-8 from epithelial cells.54 At
the same time, airway inflammation in smokers can-
not be simply described as neutrophilic inflammation.
Among individuals without asthma, in addition to
neutrophils, the number of eosinophils that infiltrate
the small airway submucosa is greater in current
smokers than never-smokers,52 and the number of
neutrophils is correlated with the numbers of eosino-
phils.52
Several studies that investigated bronchial biop-
sies9,10 and induced sputum samples7,8 from patients
with asthma showed that smoking induced neutro-
philic airway inflammation7-9 but did not aggravate
eosinophilic inflammation.7,8,10 However, these stud-
ies excluded elderly asthma patients, presumably to
exclude the comorbidity of chronic obstructive pul-
monary disease (COPD). This is an important point
for analysis, although it should be interpreted care-
fully as addressed below. In addition, Tsukioka et al.
reported that total IgE levels and specific IgE levels
against mites, cedar pollen, and Candida were higher
in current smokers with asthma than never-
smokers.55 In murine models of allergy, tobacco
smoke exposure induces bronchial hyper-reactivity,
eosinophilia, and Th2-type inflammation,56-58 which
supports that IgEeosinophilic inflammation can be
induced in current smokers with asthma.
Fractional exhaled nitric oxide (FeNO) is consid-
ered to be a useful biomarker of eosinophilic airway
inflammation.59 However, cigarette smoke is known
to consume NO that is produced in the airways via re-
actions with superoxide anion andor peroxidase-
dependent mechanisms.60 Therefore, FeNO levels in
current smokers are low61-63 and are not considered
to be a reliable marker of eosinophilic airway inflam-
mation. Studies on FeNO levels in ex-smokers have
yielded inconsistent findings.62,64,65
SMOKING CESSATION
Needless to say, smoking cessation is the best treat-
ment for smokers with asthma. In a cross-sectional
study, the number of goblet cells and mucus-positive
epithelium were increased in current smokers with
asthma compared with never-smokers with asthma,
however, there was no increase in ex-smokers.10
FEV1 in smokers with asthma improved within a
week after smoking cessation, and this improvement
increased further for an additional six weeks.66 Pa-
tients who had quit smoking for at least a year exhib-
ited restored responses to an oral corticosteroid, with
increased morning PEF values.6 In addition, sputum
neutrophil counts were decreased within six weeks of
smoking cessation.66 Therefore, many characteristics
of smokers with asthma may be normalized after
smoking cessation. However, the question remains if
smoking cessation completely reverses airway inflam-
mation or immune system responses. Indeed, the lev-
els of several sputum mediators were not decreased
after smoking cessation.67 In addition, the adjuvant ef-
fects of cigarette smoking on allergic subjects cannot
be neglected because these effects may cause persis-
tent eosinophilic inflammation after smoking cessa-
tion. Recall challenge with ovalbumin one month af-
ter the last concurrent exposure to smoking can re-
sult in ovalbumin-induced antigen-specific memory
and significantly augments eosinophilic inflammation
in mice models.68
ASTHMA IN THE ELDERLY
CLINICAL CHARACTERISTICS
Asthma may emerge at any age and at a similar rate
in all adults (approximately 5%-10%).69 Enhanced lon-
gevity in the general population may result in in-
creased numbers of elderly patients with asthma. The
term elderly adult is usually defined on the basis of
chronological, biological, or sociocultural perspec-
tives, and the cutoff age defining an individual as eld-
erly ranges from 60 to 65 years.70
Elderly patients with asthma have high rates of
hospitalization71 and mortality,29,72 possibly because
of comorbidities,72 underdiagnosis, and inadequate
treatment.71,73,74 Although elderly patients with
asthma are typically characterized as nonatopic, atopy
is not uncommon among these patients according to
some reports.75,76 Indeed, elderly patients with
asthma are sensitized to allergens at a higher rate
compared with age-matched controls (50% vs. 26%, re-
spectively).77
DECLINES IN LUNG FUNCTION
Lung function is at its maximum around 20 to 25
years of age and begins to decline thereafter, with an-
nual declines of 25-30 ml in FEV1. Of note, the esti-
mated rate of decline is not linear with age and can be
greater in the elderly.78 The putative mechanisms for
impairment of lung function in the elderly are a loss
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Table　1　Infl ammation in smoking asthmatics
Authors, 
Published year
Subjects, 
Smoking status,
Condition of treatment
Pack-years
Age, 
Mean (range) 
or mean ± SD
Samples Effects of smoking
Boulet LP, 20067 22 current smokers
27 never-smokers
No use of ICS
14.0 ± 7.6
 0 ± 0
31 (20-44)
29 (20-42)
Induced 
sputum
Neutrophil counts↑
Eosinophil counts→
Chalmers GW, 20018 31 current smokers
36 never-smokers
No use of ICS
21.0 ± 16.6
0 ± 0
36.3 ± 10.6
36.0 ± 8.9
Induced 
sputum
Neutrophils↑
(both counts and propor-
tions)
Eosinophils↓
(both counts and propor-
tions)
St-Laurent J, 20089 12 current smokers
12 never-smokers
No use of ICS
16.7 ± 2.2
 0 ± 0
32.7 ± 2.3
25.8 ± 2.3
Bronchial 
biopsies
Neutrophil elastase, 
IFN-γ, and IL-8↑
Broekema M, 200910 35 current smokers
46 ex-smokers
66 never-smokers
44% used ICS 
 3 (0-64)
15 (0.4-47)
 0 (0-0)
50 (21-64)
52 (25-68)
47 (19-71)
Bronchial 
biopsies and 
induced 
sputum
Neutrophils→ in biop-
sies (current and ex)
Eosinophils↓ in biop-
sies (current and ex)
Sputum neutrophil 
counts↓ (current)
Sputum neutrophil 
counts→ (ex)
Sputum eosinophil 
counts→ (current and ex)
Sunyer J, 200311 301 current smokers
406 ex-smokers,
713 never-smokers
34.5 ± 9.5 Blood Eosinophil proportions↓
Nagasaki T, 201391 46 current smokers
65 ex-smokers
196 never-smokers
No use of ICS
30 ± 19
27 ± 22
0 ± 0
47 ± 13
61 ± 15
49 ± 20
Blood Neutrophil counts↑
Eosinophil counts↑
of chest wall compliance and decreased supporting
tissue, such as elastic fibers, around alveolar ducts,78
which may result in enlarged air spaces and in-
creased air trapping. Elderly patients with asthma
have an accelerated rate of decline in FEV1 compared
with healthy elderly individuals4; furthermore, they
may have pronounced impairments in the small air-
ways.79 Pentosidine may be involved in one of the
mechanisms underlying the accelerated decline in
the lung function of elderly patients with asthma, al-
though further studies are warranted.
IMMUNE SYSTEM AND AIRWAY INFLAMMA-
TORY CELL PHENOTYPES
Immunosenescence or inflamm-aging is defined as
changes in innate and adaptive immune responses as-
sociated with increasing age.75,76 Age-related changes
in immune function may alter susceptibilities to anti-
gens, infection, malignancy, and autoimmunity. In the
general population, serum total and allergen-specific
IgE levels decrease with increasing age.12,75,80 Bron-
choalveolar lavage fluid (BALF) samples from elderly
healthy never-smokers without allergies showed in-
creased airway neutrophilis81 and CD4+ T cells82
when compared with samples from younger popula-
tions. The effects of increasing age on the balance be-
tween Th-1 and Th-2 cytokines can be altered by
many factors.83,84
There are few reports regarding age-related proc-
esses in the immune system, including airway inflam-
matory cell types, of patients with asthma85-87. One
study suggested that elderly patients with asthma
had significantly increased percentages of sputum
neutrophils.86 In addition, increased airway neutro-
phils in elderly patients with asthma corresponds to
increased levels of sputum neutrophil-related media-
tors such as matrix metalloproteinase 9, neutrophil
elastase, and IL-8,86 but not leukotriene B4.87 With re-
gard to eosinophils, an earlier study showed that
eosinophil activity was decreased in elderly patients
with asthma.85 Antigen-sensitized and antigen-
challenged aged mice showed higher numbers of
eosinophils in BALF than younger mice.88
Although FeNO reflects eosinophilic airway inflam-
Smoking and Aging in Asthma
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Fig.　1　Relationships between log-transformed serum IgE levels and smoking status when data 
were separately analyzed in the elderly patients (≥64 yr) (p = 0.003 using the Kruskal-Wallis test) 
and younger patients (<64 yr) with asthma. *Using the Wilcoxon rank-sum test. From reference 91.
2.5
2
1.5
1
0.5
0
3
3.5
Never
n = 145
Never-
smokers
n = 50
Ex 
n = 32
Ex-
smokers
n = 33
Current
smokers
n = 7
Current
n = 39
p = 0.0007*
p = 0.003*
p = 0.013*
youngerelderly
log IgE
(IU/mL)
Table　2　Relationships between IgE/eosinophilic infl amma-
tion and age in never-smokers
Correlation 
coefficient p value
†IgE, IU/mL -0.31 <.0001
†Blood eosinophil counts, /L -0.16 0.028
†FeNO, ppb -0.14 0.05
†Log-transformed. FeNO, fractional exhaled nitric oxide. 
From reference 91.
mation, some caution may be necessary when inter-
preting FeNO levels in the elderly. Gelb et al. showed
that FeNO and alveolar NO levels increased with in-
creasing age in healthy subjects who had never
smoked.89 They speculated that the increase in NO
levels in the elderly could be because of a decrease in
capillary blood volume and decreased NO diffusion.
Nonetheless, associations between higher FeNO lev-
els and increasing age have not yet been estab-
lished.62,65,89
SMOKING AND IMMUNOSENESCENCE IN PA-
TIENTS WITH ASTHMA
As described above, several clinical studies on
asthma found that neutrophilic inflammation may be
the main characteristic of current smokers with
asthma.7-9 However, relatively young patients, mostly
in their thirties,7-9 were examined in these studies,
probably to avoid patients with COPD as a comorbid-
ity (Table 1). Mitsunobu et al. showed that ex-
smoking increased the rate of atopic predisposition
among elderly patients with asthma.90 Therefore, the
effects of smoking on eosinophilic inflammation in pa-
tients with asthma, including the elderly, remain un-
determined.
To determine the effects of smoking on IgE
eosinophilic inflammation in elderly patients with
asthma, we performed a cross-sectional analysis of
the associations of serum IgE levels, blood eosinophil
counts, and FeNO levels with smoking and age in
steroid-naïve patients with asthma (n = 307).91 Cur-
rent smokers were excluded when analyzing factors
that contributed to FeNO. We found that serum IgE
levels, blood eosinophil counts, and FeNO levels con-
sistently decreased with increasing age in never-
smokers (Table 2). When patients were stratified on
the basis of age, IgE levels and blood eosinophil
counts were higher in current smokers, followed by
ex-smokers and never-smokers only in the elderly
group (64 years of age)70 (Fig. 1, 2). In addition, ex-
smokers exhibited higher FeNO levels compared
with never-smokers in the elderly group (Fig. 3). For
younger patients (<64 years of age), significant differ-
ences with regard to smoking status were only ob-
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Fig.　2　Relationships between log-transformed blood eosinophil counts and smoking status when data 
were separately analyzed in the elderly patients (p = 0.005 using the Kruskal-Wallis test) and younger 
patients with asthma (p = 0.050 using the Kruskal-Wallis test). *Using the Wilcoxon rank-sum test.
p = 0.010*
p = 0.013*
p = 0.006*
log Eo
(cells/L)
Never
n = 146
Never
n = 50
Ex 
n = 32
Ex 
n = 33
Current
n = 7
Current
n = 39
2.5
2
1.5
1
0.5
0
3
3.5
4
elderly younger
Fig.　3　Relationships between log-transformed fractional exhaled nitric oxide (FeNO) levels and 
smoking status when data were separately analyzed in the elderly and younger patients with asth-
ma. *Using the Wilcoxon rank-sum test.
p = 0.014* p = 0.025*
elderly younger
log FeNO
(ppb)
Never
n = 146
Never
n = 50
Ex 
n = 33
Ex 
n = 32
2.5
2
1.5
1
0.5
0
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served for blood eosinophil counts (p = 0.05). Asso-
ciation analyses using continuous variables yielded
similar findings, which were more pronounced when
analyses were confined to atopic patients with asthma
(data not shown).91
These findings may suggest that current and ex-
smoking attenuates age-related decreases in IgE lev-
els and maintain eosinophilic inflammation, particu-
larly in atopic asthmatics. One possible mechanism
underlying persistent eosinophilic inflammation in
current and ex-smokers is thymic stromal lym-
phopoietin (TSLP), a pro-allergic cytokine induced by
smoking, viral infection, andor allergen exposure,
which promotes Th2-skewed immune responses. We
found that sputum TSLP levels (n = 139) were weakly
but positively correlated with smoking pack-years (ρ
= 0.29; p = 0.0005) and the percentage of sputum
eosinophils (ρ = 0.17; p = 0.048). Moreover, sputum
TSLP levels in current smokers (14.1 ± 17.7 pgmL; p
= 0.008) and ex-smokers (14.4 ± 22.6 pgmL; p =
0.016) were significantly higher than those in never-
smokers (6.4 ± 15.7 pgmL).91 TSLP may be involved
in persistent eosinophilic inflammation in current and
ex-smokers.
CONCLUSIONS
Asthma is a common disease, even among smokers
and elderly individuals. Smokers or older patients
with asthma may have altered baseline airway inflam-
mation with increased neutrophilic inflammation
compared with never-smokers or younger patients.
However, it is possible that current smoking and ex-
smoking attenuates age-related decreases in IgE lev-
els and maintains eosinophilic inflammation, particu-
larly in atopic patients with asthma. Clinically, the
presence of both neutrophilic and eosinophilic inflam-
mation should be fully recognized during the man-
agement of elderly smokers with asthma. This review
may expand our understanding on the effects of
smoking and aging on asthma by offering insights
into their interactions in patients with atopic asthma.
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